vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['urothelial', 'thor study']
dr. . serves as discussant and panelist for a late-breaking abstract session on the phase 3 thor study for metastatic urothelial cancer, today at 7:42am cdt in hall d1.
#asco23 #lba4619
learn more&gt; 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.